Asset

Total 208, page 8/11

No. Organization Therapeutic Area Product Type Title
34 Cancer Research Horizons Oncology Small molecule CDC7 Inhibitors
34 University of California, San Diego Oncology Vaccine Encapsulation Method of Adenoviral Vectors in Liposomes
33 University of California, San Diego Inflammatory disease Small molecule Identification of Novel NLRP3 Inflammasome Inhibitors
33 NIH Oncology Small molecule Small Molecule Ephrin (Eph) Tyrosine Kinase Inhibitors for the Treatment of Colorectal Cancer and Other Eph Growth-dependent Solid Tumors
32 Boston University Oncology Small molecule TFCP2 Transcription Factor Inhibitors
32 University of California, San Diego Oncology Cell therapy Macrophage Programming for Immunotherapy
31 University of California, San Diego Oncology Small molecule Novel Cyclic Dinucleotide Analogues as STING Agonists
31 Weill Cornell Medicine Oncology Antibody Conjugated Anti-CDCP1 Antibody-Drug Conjugate for the Treatment of Solid Tumors
30 Weill Cornell Medicine Oncology Antibody Anti-ART1 Monoclonal Antibody for Improved Anticancer Immunotherapy
30 The Ohio State University Oncology, Hematology Small molecule HOSU-3, DHODH Inhibitor for Acute Myeloid Leukemia
29 The Ohio State University Oncology Small molecule AHR Inhibitor for Hematological Malignancies
29 Stanford SPARK Program Oncology Antibody Enhancing Host-anti-tumor Response by Preventing Thrombin Cleavage of Osteopontin
28 Ramot At Tel Aviv University Oncology Peptide Therapeutic Targeting of CD45 by Novel Agents to Immunotherapy Non-responders Tumors
28 The Ohio State University Oncology Small molecule Mps1 Kinase Inhibitors As Mitotic Regulator for Cancer Therapy
27 The Ohio State University Hematology Small molecule DHODH Inhibitors for Treatment of Hematological Malignancies
27 Ramot At Tel Aviv University Oncology Oncolytic Virotherapy EHDV-TAU, a Novel Oncolytic Virus
26 NIH Oncology Protein Chimeric Adaptor Proteins (CAPs) Containing a Linker for Activation of T Cells (LAT) and a Kinase Domain for Use in T Cell-Based Immunotherapy
26 The Ohio State University Oncology Vaccine Activated B cells as Therapeutic Cancer Vaccine Platform
25 The Ohio State University Oncology Small molecule Orally Bioavailable and Brain Penetrant Mps1/TTK inhibitors as cancer therapeutics
25 FDA Technology Transfer Oncology Antibody Chimeric Immunotoxins Targeting IL-13Rα2 Positive Human Cancers

TOP